AbbVie is a global, research-based biopharmaceutical company focused on developing advanced therapies that address some of the world’s most serious diseases. Our goal is to improve patients’ health and quality of life – with innovative specialty medicines, focused research and groundbreaking initiatives for patients.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives.

In addition, Amgen’s Swiss affiliate is located in the same building and was established shortly after. Today, the Swiss branch employs around 100 staff members.

Over the past four decades, Amgen has launched an extensive portfolio of innovative medicines, with 16 currently marketed in Europe and the industry’s largest collection of modalities, that tackle some of the world’s most serious diseases. We focus on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation.

ARTTIC Innovation GmbH, a company of the PNO Consultants Group, the European leader in collaboration engineering, consultancy and management services for international research and technology related partnerships. The team at ART has been built since 2006 and has set up and managed numerous projects in EU funding programmes. Currently, ART is collaborating with multi-national consortia in 28 EU funded projects. ARTTIC Innovation GmbH builds and assists collaborative undertakings and in particular European research consortia and networks from all businesses and research sectors, small and large, private and public, to ensure their collaborative innovation ventures are as successful as possible.

ASSOCIATION EISBM (EISBM) is a non-profit research association established to foster the development of systems approaches to fundamental biological questions and their application to important medical problems. Systems biology represents a groundbreaking approach to overcome the current limitations of disease complexity and drug discovery. The development of systems biology and medicine will lay the foundation for a prospective medicine that will be predictive, personalised, preventive and participatory (4P-Medicine). 

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.

Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. With our innovative solutions, we are responding to the global challenges in medical care and the need to safeguard an adequate food supply. We have a global network of research and development sites employing approximately 15,100 researchers.

The Center for Advanced Systems Understanding (CASUS) at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) was founded 2019 in Görlitz/Germany and pursues data-intensive interdisciplinary systems research in such diverse disciplines as earth system research, systems biology or materials research. The goal of CASUS is to create digital images of complex systems of unprecedented fidelity to reality with innovative methods from mathematics, theoretical systems research, simulations as well as data and computer science to give answers to urgent societal questions.

The European Association of Urology (EAU) was founded in 1972, and is the leading authority within Europe on urological practice, research, and education. The EAU membership network of over 19,000 members encompasses the whole of Europe and also extends to Asia, Africa, South America and the Middle East. The EAU envisions a Europe where all medical professionals in the field of urology, and its subspecialties, work together with EU citizens to ensure that the highest quality, evidence-based urological care is  received by all patients.

The European Institute of Oncology (IEO) is a comprehensive cancer center with a strong focus on fundamental cancer research. The main goal of our Institute is to fill the gap between clinics and research, including basic, translational and clinical research. At IEO basic scientists and clinicians work together to have an integrated scientific workflow.

In partnership with European Respiratory Society, European Lung Foundation (www.europeanlung.org) brings patients and the public together with healthcare professionals to improve lung health and advance diagnosis, treatment, and care.

The EORTC is a non-profit international research organization created under Belgian law in 1962. Since its creation, the EORTC has contributed to improve the survival rates for several types of cancer through translational and clinical research. Over 50 EORTC clinical trials are open to patient recruitment at any given time with over 50,000 patients who are in follow-up, and a quality assured database of more than 180,000 patients. Both multinational and multidisciplinary, the EORTC Network comprises more than 2,830 direct collaborators from all disciplines involved in cancer treatment and research in more than 730 university hospitals in over 48 countries.

The European Respiratory Society (ERS) is an international non-for-profit organisation that brings together physicians, healthcare professionals, scientists and other experts working in respiratory medicine. It is one of the leading medical organisations in the respiratory field, with a growing membership representing over 170 countries. Its mission is to promote respiratory health and to alleviate suffering from respiratory disease.

Erasmus University Medical Center Rotterdam (EMC) is committed to a healthy population and excellence in healthcare through research and education (www.erasmusmc.nl). As an academic hospital, Erasmus MC is committed both to achieving a healthy population and to pursuing excellence in healthcare through research and teaching. To this end, we combine fundamental, translational, and clinical research with patient care and a range of teaching activities. The center has broad expertise in various research fields, ranging from fundamental and clinical domains to public health and prevention, with an annual research budget of around €140 million. Erasmus MC holds over 90 projects funded by the European Commission, of which 85 Horizon 2020 projects including collaborations with partners from 56 countries worldwide. Bibliometric indicators place Erasmus MC in the top 20 of clinical medicine worldwide; its publications are cited 1.89 times the world average. In addition to scientific research, patient care and education are core tasks of Erasmus MC. 

The German Cancer Society includes about 8,000 individual scientific members organized in 25 working groups, 16 regional cancer societies and 36 sponsors from research-based pharmaceutical industries, scientific publishers and health insurances. All our members are active in the research and treatment of cancer with the aim to address our joint goal: the fight against cancer.

GMV is a multinational company based in Spain, a privately-owned technological business group with an international presence. Founded in 1984. GMV is present in more than 20 countries where it participates in projects where innovation, high technology and security are needed. In the last 10 years, GMV has attained a leadership position in the Health sector, creating its own products and collaborating with important clients and partners, applying the internal know-how in the development of advanced technological solutions.

Helios is Europe’s leading hospital operator, with approximately 120,000 employees. Together with Quirónsalud in Spain and Latin America, Helios Kliniken in Germany is part of the holding Helios Health. Every year about 20 million patients choose Helios for medical treatment. Helios Germany operates 89 acute care hospitals, about 130 outpatient clinics, six prevention centers and treats approximately 5.2 million patients annually, of whom 4.1  million are outpatients.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare; a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society.

ITTM (Information Technology for Translational Medicine) S.A. is a spin-off company of the Luxembourg Centre for Systems Biomedicine which is specialised in data integration and knowledge management. ITTM offers solutions for improved data quality, data models (e.g., OMOP CDM), system integration & process optimization (incl. hosting of knowledge platforms like tranSMART, Atlas, Arachne or similar). ITTM offers interwoven services in two areas:

The Faculty of Medicine and the University Hospital of Ludwig-Maximilians-Universität in Munich (LMU) are among European‘s leading centers of academic medicine. LMU University Hospital is the second largest university hospital in Germany and one or the largest in Europe. Together with its patients and partners it strives for groundbreaking research and treatments in a caring environment. Thanks to its achievements in research, teaching, and patient care, the university ospital enjoys an excellent reputation both nationally and internationally.

Lund University (LU) (www.lu.se) is consistently ranked among the world’s top 100 universities. One of the strategic research areas at the Medical Faculty is cancer research. Skåne University Hospital is associated with LU and our prostate cancer research programme is highly respected on the international arena. The Swedish National cancer registries are also unique compared to most other countries. This platform, together with a long-term tradition of epidemiological research, is very suitable for the current application. LU has received the EU’s certification, HR Excellence in Research. HR Excellence in Research certification means that a higher education institution fulfils many of the stringent EU requirements for a responsible and professional employer, and that it has a commitment to continuous quality management LU have participated in several prostate cancer projects sponsored by the EU. 

Maastricht University is a top-ranked international university, renowned for the quality of the research undertaken in many areas and hosts 16.800 students in international BA, MA and graduate programs, and 3.500 (FTE) employees. Researchers at UM work in multidisciplinary teams and in close cooperation with international institutes, business and industry. UM and the University hospital Maastricht (azM) work together under the umbrella organisation Maastricht University Medical Center+ (Maastricht UMC+) and has three mutually reinforcing core tasks: patient care, research, and education and Training: train new generations of doctors and researchers.

Founded in 1998 MUTABOR is one of the biggest independent agencies for design and transformation in Germany. At offices in Hamburg and Munich about 170 employees work for international clients in more than 12 countries. Next to units for Brand Strategy, Brand Design,

Owkin is a French-American startup that specialises in AI and Federated Learning for medical research. Owkin’s mission is to connect the global healthcare industry through the safe and responsible use of data and application of artificial intelligence, for faster and more effective research. Owkin leverages life science and machine learning expertise to make drug development and clinical trial design more targeted and cost effective.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines.  Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.

Queen Mary University London (QMUL) is ranked 9th in research quality in the 2014 UK Research Excellence Framework (REF) with its School of Medicine ranked in the top 10 of medical schools in the UK. QMUL has c.150 H2020 awards, including a several IMI2 awards.

Region Uppsala works with care, culture, public transport, and regional development. This means coordinating and collaborating with many other stakeholders in areas such as transport infrastructure, business and the labor market, tourism, and public health.

Region Uppsala has the main responsibility for healthcare for residents of Uppsala County, while at the same time being a national and international center for highly specialised healthcare. Region Uppsala works actively to promote health, prevent diseases, and provide basic healthcare to the residents of Uppsala County. At the same time, highly specialised care is provided in many areas, where patients come from all over Sweden and abroad.

Region Uppsala works with care, culture, public transport, and regional development. This means coordinating and collaborating with many other stakeholders in areas such as transport infrastructure, business and the labor market, tourism, and public health.

Region Uppsala has the main responsibility for healthcare for residents of Uppsala County, while at the same time being a national and international center for highly specialized healthcare. Region Uppsala works actively to promote health, prevent diseases, and provide basic healthcare to the residents of Uppsala County. At the same time, highly specialised care is provided in many areas, where patients come from all over Sweden and abroad.

Smart Reporting GmbH is a digital health start-up based in Munich, Germany. Smart Reporting’s products support physicians in generating structured, standardized, and machine-readable medical reports. Smart Reporting was developed as an open platform and network of physicians and provides optimized reporting templates based on decision trees with pre-specified options.

The Foundation University Institute for Primary Health Care Research Jordi Gol i Gurina (IDIAPJGol) was created in 1995 as a non-profit organization promoted by the Institut Català de la Salut (Catalan Health Institute, ICS), which is a public entity linked to the Department of Health providing health care in Catalonia (Spain). IDIAPJGol’s main objective is to produce novel and translational information by promoting, developing and managing research in Primary Health Care (PHC) in Spain and to foster training, the dissemination of results and application to the health services. The close collaboration with the Institut Català de la Salut (ICS) facilitates the development of research projects in a wide range of health services.

The University of Aberdeen (UoA) was founded in 1495, is Scotland’s third oldest University and is the fifth oldest in the UK. Aberdeen is an international university built on serving one of the most dynamic regions of Europe. With over 13,900 students (over 19% are mature graduates), and over 3,000 staff from more than 120 nationalities, the UoA is at the forefront of teaching and research in medicine, the humanities and sciences. The Institute of Medical Sciences (IMS), where the Academic Urology Unit (AUU) and key staff are located, is the flagship research institution of the University. 

ttopstart is a science and business consulting company that serves leading researchers and innovative companies in the fields of life sciences, medical technology and health. Our professionals have a shared passion for making the complex simple, realising meaningful impact, and pushing through barriers. Our approaches build upon proven and tailored consulting methods and a deep understanding of the sector. It is our goal to accelerate the introduction of impactful innovations. ttopstart consists of a team of creative, ambitious professionals who combine knowledge of science with commercial skills.

The University of Tartu (UT, est. 1632) is among leading universities in the Central and Eastern Europe according to several international rankings. With over 14,000 students, 1,500 academic staff and long history as a classical university, it is the main powerhouse of research in Estonia. The Estonian Biobank of the University of Tartu is one of the leading international population based biobanks established already in 2000 after passing a national gene research act in Estonia, the first of a kind.

The University of Oxford has been named for four consecutive years the world’s number one university by the Times Higher Education World University Rankings. Researchers across Oxford are at the forefront of global efforts to understand, prevent, and treat many health problems including cancer. The Center for Statistics in Medicine (CSM), NDORMS hosts Prof Prieto Alhambra’s research group. CSM supports medical research from many therapeutic areas. The group led by Prof D Prieto-Alhambra is focused on the generation of real world evidence for disease characterization, prediction modelling, and causal inference. 

The University of Vienna is a research university enjoying high international visibility. Its Law Faculty is the oldest and largest legal faculty in the German-speaking world, currently hosting about 10,000 students and 600 employees. The Department of Innovation and Digitalisation in Law was founded in October 2017, as a part of the Vienna School of Law, to deal with emerging legal   questions   surrounding   IT/IP   law  from  a European perspective, with an emphasis on data protection and data security law.

Uppsala University (UU) is a Swedish university, founded in 1477, that continuously ranks among the top 100 universities in the world. The University’s nearly 5,000 researchers and teachers conduct world-leading research and offer a vast number of courses. UU stands out for its multiple areas of academic strength in which research, education and collaboration are integrally connected. Among the University’s alumni are 15 Nobel Prize winners, of which 8 received their prizes for discoveries made during their  time  at Uppsala  University. 

Ydeal is a SME specialized in software solutions for healthcare applications (eHealth), which allows them to deliver individually tailored products to the needs of specific stakeholders, addressing different user groups, namely made-to-measure projects for national health services, enterprises, healthcare professionals and patients. Ydeal has a strong portfolio of software development in the field of prostate cancer, such as the Rotterdam Prostate Cancer Risk Calculator and PRIAS (Prostate Cancer Research International Active Surveillance), an online platform where doctors can manage men with low-risk prostate cancer on active surveillance.